ZVRA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Zevra Therapeutics Inc (ZVRA) is not a strong buy at the moment for a beginner investor with a long-term focus. While there are positive catalysts such as analyst optimism and growth potential for Miplyffa, insider selling, weak recent financial performance, and the lack of strong trading signals suggest holding off on immediate investment. The stock's technical indicators are neutral, and options data reflects mixed sentiment. Waiting for clearer signals or improved financial results may be prudent.
The technical indicators for ZVRA are mixed. The MACD is above 0 and positively contracting, suggesting mild bullish momentum. The RSI is neutral at 46.755, indicating no clear overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but key support and resistance levels show limited upside potential in the short term (Pivot: 10.171, R1: 10.783, S1: 9.56).
Analysts have issued Buy ratings with a price target of $23, citing growth potential for Miplyffa and potential EU approval. Gross margin increased significantly in the latest quarter, indicating operational efficiency.
Insiders are selling heavily, with a significant 809.12% increase in selling activity over the last month. Financial performance in the latest quarter showed a sharp decline in net income (-133.10% YoY) and EPS (-129.85% YoY). Stock trend analysis suggests a high probability of short-term declines (-5.09% in the next week, -12.56% in the next month).
In Q4 2025, revenue increased by 183.36% YoY to $34.13 million, but net income dropped by -133.10% YoY to $11.83 million. EPS also fell by -129.85% YoY to 0.2. Gross margin improved significantly to 94.62%, up 25.76% YoY.
Analysts from BTIG and Guggenheim have issued Buy ratings with a price target of $23, citing strong growth potential for Miplyffa and other catalysts such as EU approval and patent term extensions. However, these are long-term drivers and may not immediately impact the stock price.
